| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.02 |